CN1213550A - Medicine for treating diabetes and its prepn. method - Google Patents

Medicine for treating diabetes and its prepn. method Download PDF

Info

Publication number
CN1213550A
CN1213550A CN 97119105 CN97119105A CN1213550A CN 1213550 A CN1213550 A CN 1213550A CN 97119105 CN97119105 CN 97119105 CN 97119105 A CN97119105 A CN 97119105A CN 1213550 A CN1213550 A CN 1213550A
Authority
CN
China
Prior art keywords
radix
rhizoma
medicine
fructus
rhizoma atractylodis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 97119105
Other languages
Chinese (zh)
Inventor
何立祥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 97119105 priority Critical patent/CN1213550A/en
Publication of CN1213550A publication Critical patent/CN1213550A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A medicine for treating diabetes with unique curative effect is prepared from 24 Chinese-medicinal materials such as plantain seed, white tuckahoe, dogwood fruit, siberian solomonseal rhizome, schisandra fruit, etc.

Description

A kind of medicine for the treatment of diabetes and preparation method thereof
The present invention relates to a kind of medicine for the treatment of diabetes, specifically, is a kind of Chinese medicine composition, relates to the preparation method of this medicine in addition.
The medicine of many treatment diabetes known in the state of the art, the Western medicine great majority of for example treating diabetes often make the patient have dependency for insulin type, can not make the patient set up independently homergy circulation, do not have therapeutical effect in fact at all.And the Chinese medicine of existing treatment diabetes can only improve some symptoms of patient, the not remarkable and poor stability of curative effect.
Purpose of the present invention just provides a kind of medicine of evident in efficacy and stable treatment diabetes of pure Chinese medicine.
Another object of the present invention provides the preparation method of this medicine.
It is the active part that raw material adopts conventional extracting method to make that drug main of the present invention will contain the Chinese crude drug of selecting following weight ratio for use: stone chinaberry 20-30, Herba Dianthi 20-30, Semen Plantaginis 20-30, Poria 15-25, Fructus Corni 1-10, Rhizoma Polygonati 20-30, Rhizoma Atractylodis Macrocephalae 15-25, porcine bladder 40-50, Fructus Schisandrae Chinensis 20-30, Periostracum Cicadae 10-20, Rhizoma Anemarrhenae 20-30, Radix Ophiopogonis 20-30, Rhizoma Dioscoreae 55-65, Radix Rehmanniae 55-65, Radix Trichosanthis 20-30, Radix Scrophulariae 25-35, Radix Astragali 25-35, Rhizoma Atractylodis 10-20, Gypsum Fibrosum 100-150, Cordyceps 20-30, Radix Ginseng 20-30, Radix Polygoni Multiflori 20-30, Radix Puerariae 20-30, Radix Salviae Miltiorrhizae 20-30, Fructus Lycii 10-20; Be preferably: stone chinaberry 24, Herba Dianthi 24, Semen Plantaginis 24, Poria 20, Fructus Corni 6, Rhizoma Polygonati 24, Rhizoma Atractylodis Macrocephalae 20, porcine bladder 44, Fructus Schisandrae Chinensis 24, Periostracum Cicadae 12, the Rhizoma Anemarrhenae 24, Radix Ophiopogonis 24, Rhizoma Dioscoreae 60, the Radix Rehmanniae 60, Radix Trichosanthis 24, Radix Scrophulariae 30, the Radix Astragali 30, Rhizoma Atractylodis 12, Gypsum Fibrosum 120, Cordyceps 24, Radix Ginseng 27, Radix Polygoni Multiflori 27, Radix Puerariae 24, Radix Salviae Miltiorrhizae 24, Fructus Lycii 18; Wherein: porcine bladder is preferably dry powder.
Conventional extracting method of the present invention comprises decocting method, infusion process, percolation, reflux extraction, decoction and alcohol sedimentation technique and ethanol extract from water precipitation etc.The used extraction solvent of the present invention comprises water and Different concentrations of alcohol.Extraction time decides according to diverse ways.General decocting method decocting time is 0.5-1.5 hour; Reflux extraction was generally 1-2 hour.
In addition, medicine of the present invention can also be chosen wantonly and contain pharmaceutically acceptable various additives, and these additives comprise filler, binding agent, wetting agent, disintegrating agent, surfactant, lubricant, diluent etc.
According to the present invention, use the conventional formulation technology of this area to make pharmaceutically various preparations to this medicine, the preferred oral administration, wherein representative dosage forms is oral liquid, tablet, unguentum, powder agent, capsule etc.
Medicine of the present invention is progressively stablized curative effect according to the secular clinical experience of inventor, medicine biggest advantage of the present invention is the various staggered compound type that is applicable to diabetes, be not limited to typing, effect with supplementing QI and nourishing YIN, strengthening spleen, tonifying kidney and blood circulation promoting and blood stasis dispelling, various types of diabetes are all had unique curative effect, and cure rate is 50%, total effective rate 90%, and do not have side effect such as dependency, can help making the patient to erect normal metabolic cycles from health is built-in.
Embodiment 11) respectively by following consumption raw materials weighing (unit kilogram): stone chinaberry 24, Herba Dianthi 24, Semen Plantaginis 24, Poria 20, Fructus Corni 6, Rhizoma Polygonati 24, Rhizoma Atractylodis Macrocephalae 20, porcine bladder 44, Fructus Schisandrae Chinensis 24, Periostracum Cicadae 12, the Rhizoma Anemarrhenae 24, Radix Ophiopogonis 24, Rhizoma Dioscoreae 60, the Radix Rehmanniae 60, Radix Trichosanthis 24, Radix Scrophulariae 30, the Radix Astragali 30, Rhizoma Atractylodis 12, Gypsum Fibrosum 120, Cordyceps 24, Radix Ginseng 27, Radix Polygoni Multiflori 27, Radix Puerariae 24, Radix Salviae Miltiorrhizae 24, Fructus Lycii 18; 2) raw material is mixed, add water logging and cross powder, 100 ℃ decocted 1 hour, filtered, and filtrate for later use adds water logging with filtering residue and crosses powder, and 100 ℃ decocted 0.5 hour, filtered merging filtrate; 3) in the filtrate of above-mentioned gained, slowly add ethanol and make and contain the alcohol amount and reach 80%, filter,, obtain active part of the present invention again with decompression filtrate recycling ethanol.Embodiment 2
With the active part drying that obtains among the embodiment 1, pulverized the 80-100 mesh sieve.Adding dry starch 10% mixing, is that wetting agent system soft material is crossed the granulation of 16 mesh sieves with 95% ethanol, dries, and granulate adds magnesium stearate 1%, and mixing is after the calculating sheet is heavy, with 10mm biconvex punch die tabletting, coating.Embodiment 3
With the active part drying that obtains among the embodiment 1, wear into fine powder, incapsulate.

Claims (3)

1. a medicine for the treatment of diabetes is characterized in that it mainly contains the Chinese crude drug of selecting following weight ratio for use is the active part that raw material adopts conventional method to make: stone chinaberry 20-30, Herba Dianthi 20-30, Semen Plantaginis 20-30, Poria 15-25, Fructus Corni 1-10, Rhizoma Polygonati 20-30, Rhizoma Atractylodis Macrocephalae 15-25, porcine bladder 40-50, Fructus Schisandrae Chinensis 20-30, Periostracum Cicadae 10-20, Rhizoma Anemarrhenae 20-30, Radix Ophiopogonis 20-30, Rhizoma Dioscoreae 55-65, Radix Rehmanniae 55-65, Radix Trichosanthis 20-30, Radix Scrophulariae 25-35, Radix Astragali 25-35, Rhizoma Atractylodis 10-20, Gypsum Fibrosum 100-150, Cordyceps 20-30, Radix Ginseng 20-30, Radix Polygoni Multiflori 20-30, Radix Puerariae 20-30, Radix Salviae Miltiorrhizae 20-30, Fructus Lycii 10-20.
2. according to the medicine of claim 1, it is characterized in that it mainly contains the Chinese crude drug of selecting following weight ratio for use is the active part that raw material adopts conventional method to make: stone chinaberry 24, Herba Dianthi 24, Semen Plantaginis 24, Poria 20, Fructus Corni 6, Rhizoma Polygonati 24, Rhizoma Atractylodis Macrocephalae 20, porcine bladder 44, Fructus Schisandrae Chinensis 24, Periostracum Cicadae 12, the Rhizoma Anemarrhenae 24, Radix Ophiopogonis 24, Rhizoma Dioscoreae 60, the Radix Rehmanniae 60, Radix Trichosanthis 24, Radix Scrophulariae 30, the Radix Astragali 30, Rhizoma Atractylodis 12, Gypsum Fibrosum 120, Cordyceps 24, Radix Ginseng 27, Radix Polygoni Multiflori 27, Radix Puerariae 24, Radix Salviae Miltiorrhizae 24, Fructus Lycii 18.
3. according to the medicine of claim 1 or 2, wherein porcine bladder is a dry powder.
CN 97119105 1997-10-07 1997-10-07 Medicine for treating diabetes and its prepn. method Pending CN1213550A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 97119105 CN1213550A (en) 1997-10-07 1997-10-07 Medicine for treating diabetes and its prepn. method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 97119105 CN1213550A (en) 1997-10-07 1997-10-07 Medicine for treating diabetes and its prepn. method

Publications (1)

Publication Number Publication Date
CN1213550A true CN1213550A (en) 1999-04-14

Family

ID=5175191

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 97119105 Pending CN1213550A (en) 1997-10-07 1997-10-07 Medicine for treating diabetes and its prepn. method

Country Status (1)

Country Link
CN (1) CN1213550A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301737C (en) * 2005-03-22 2007-02-28 李辉 Chinese medicinal preparation for treating diabetes and its preparation method
CN100444864C (en) * 2004-11-04 2008-12-24 苗毅韧 Chinese medicinal formulation for rehabilitating pancreatic islet function and decreasing blood sugar and preparation process thereof
CN101828660B (en) * 2010-05-13 2012-04-18 山东森健生物科技发展有限公司 Health-care food for hyperglycemia patient
CN103463407A (en) * 2013-03-24 2013-12-25 季成玉 Body regulating and blood sugar reducing capsule
CN104922416A (en) * 2015-05-29 2015-09-23 张锐 Chinese medicinal formula for controlling diabetes mellitus and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100444864C (en) * 2004-11-04 2008-12-24 苗毅韧 Chinese medicinal formulation for rehabilitating pancreatic islet function and decreasing blood sugar and preparation process thereof
CN1301737C (en) * 2005-03-22 2007-02-28 李辉 Chinese medicinal preparation for treating diabetes and its preparation method
CN101828660B (en) * 2010-05-13 2012-04-18 山东森健生物科技发展有限公司 Health-care food for hyperglycemia patient
CN103463407A (en) * 2013-03-24 2013-12-25 季成玉 Body regulating and blood sugar reducing capsule
CN103463407B (en) * 2013-03-24 2016-06-08 季成玉 Reason machine Jiangtang capsule
CN104922416A (en) * 2015-05-29 2015-09-23 张锐 Chinese medicinal formula for controlling diabetes mellitus and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1686529A (en) Ready prepared Chinese medicine for treating diabetes
CN104998063A (en) Anti-fatigue pharmaceutic preparation
CN101279012A (en) Chinese medicine tea for weight reduction, toxin elimination and beauty treatment and matching Chinese medicinal composition
CN102406714B (en) Pharmaceutical composition favorable for defaecation and preparation method thereof
CN1213550A (en) Medicine for treating diabetes and its prepn. method
CN1110924A (en) Effective drug for gastric disease
CN101391092B (en) Chinese patent medicine for curing diabetes and preparation method thereof
CN1336218A (en) Prepn. of wetness-evil eliminating and dyspepsia relieving medicine tablet
CN106177494A (en) A kind of Herba Dendrobii extract buccal tablet and preparation method thereof
CN1056064C (en) Medicine for curing liver cancer and its making method
CN101537099A (en) Chinese traditional medicine composition for curing chronic nephritis and preparation method thereof
CN104127603A (en) Preparation process of lipid-lowering tablet
CN1181966A (en) Medicine for senile dementia and its preparation
CN1555867A (en) Chinese herbal medicinal compositon for treating prostate disease
CN1182858C (en) Heart-nourishing tea capsule and its prepn
CN110302165B (en) Preparation method of concentrated water-paste pill for Chinese medicinal prescription preparation
CN1213551A (en) Medicine for treating heperosteogeny and its prepn. method
CN1161144C (en) Elmination of toxicant and fat-lowering capsule and its preparation technology
CN1217204A (en) Medicine for nourishing muscle and recovering physical strength, and preparation method therefor
CN1259344A (en) Prepn. technique for Chinese traditional medicine capsule
CN1118295C (en) Chinese herb medicine composition with kidney-reinforcing and blood circulation-promoting functions
CN105535421A (en) Non-insulin-dependent diabetes mellitus traditional Chinese medicine dispersible tablets and preparation method thereof
CN1416848A (en) Capsule for treating chronic hepatitis B and its prepn
CN1302635A (en) Medical capsule for dredging channels and lowering blood pressure and its preparing process
CN1481874A (en) Capsule for fortifying kidney and nourishing qi and its preparation mehtod

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication